Intelligence Β· Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe β€” phase, modality, and trial IDs.

Programs
121

Quick answer

United Therapeutics Europe has 121 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial
  2. Trazodone

    United Therapeutics Europe Ltd

    Sleep Apnea

    approved small molecule active

    1 trial
  3. Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    3 trials
  4. Triamcinolone acetonide-Ketorolac-Ropivacaine

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved small molecule active

    1 trial
  5. Vancomycin

    United Therapeutics Europe Ltd

    Open Fracture

    approved small molecule active

    1 trial
  6. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial
  7. Zithromax

    United Therapeutics Europe Ltd

    Asthma

    approved small molecule completed

    1 trial
  8. Zoledronate

    United Therapeutics Europe Ltd

    Hip Fractures

    approved small molecule active

    1 trial
  9. allopurinol

    United Therapeutics Europe Ltd

    Gout

    approved small molecule completed

    1 trial
  10. artemether lumefantrine

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial
  11. artemether-lumefantrine (ALN)

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial
  12. combined fixed dose combination

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    1 trial
  13. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial
  14. hylan G-F 20

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved other completed

    1 trial
  15. imiquimod

    United Therapeutics Europe Ltd

    Anal Dysplasia

    approved small molecule terminated

    1 trial
  16. inhaled treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    3 trials
  17. iron and zinc combined

    United Therapeutics Europe Ltd

    Anemia

    approved other completed

    1 trial
  18. ketamine

    United Therapeutics Europe Ltd

    Acute Pain

    approved small molecule terminated

    1 trial
  19. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial
  20. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial
  21. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial
  22. sodium iodide

    United Therapeutics Europe Ltd

    Transient Hypothyroxinemia

    approved small molecule completed

    1 trial
  23. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    approved small molecule completed

    1 trial
  24. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial
  25. treprostinil sodium

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    approved small molecule terminated

    2 trials

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

121 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs